Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Nucl Cardiol. 2019 Jun 24;27(3):849–861. doi: 10.1007/s12350-019-01786-w

Table 2.

Protocol and Metabolic Parameters

Parameter Mean ± SD
N (%)

Protocol parameters
 FDG dose (mCi) 9.1 ± 0.8
 Time to imaging following FDG injection (min) 59 ± 13
 Diet adherence 111 (100%)
 Heparin administration 111 (100%)
 Adequate myocardial suppression 106 (95.5%)
Metabolic parameters
 Fasting glucose (mg/dL) 100.9 ± 39.6
 Glucose baseline Pre-FDG injection (mg/dL) 97.1 ± 36.5
 Glucose post-UFH (mg/dL) 96.2 ± 37.1
 C-peptide baseline Pre-FDG injection (ng/mL) 2.9 ± 2.5
 C-peptide post-UFH (ng/mL) 2.8 ± 2.5
 Insulin level baseline Pre-FDG (μU/mL) 12.8 ± 13.4
 Insulin level post-UFH (μU/mL) 12.5 ± 13.3
 FFA fasting (mmol/L) 0.74 ± 0.33
 FFA post-test meal drink/pre-UFH/pre-FDG injection (mmol/L) 0.87 ± 0.32
 FFA post-UFH (mmol/L) 1.48 ± 0.90
 TG fasting (mg/dL) 154.7 ± 199.6
 TG post-test meal drink/pre-UFH/Pre-FDG injection (mg/dL) 159.5 ± 178.8
 TG post-UFH (mg/dL) 113.8 ± 178.4
 Background FDG activity aorta (SUVmean) 2.1 ± 0.4
 Myocardial FDG activity mid-septal wall (SUVmax)a 1.8 ± 1.0
 Myocardial FDG activity mid-lateral wall (SUVmax)a 1.8 ± 1.3
a

Denotes SUVmax in ROI measuring normal myocardium